Bayer Posts Strong Phase III Results for Asundexia...
Category : Clinical Trial Update 26 November 2025Bayer has shared encouraging topline results from its OCEANIC-STROKE Phase III trial, testing asunde...
Clinical Trial Update
Viking Therapeutics to Join Piper Sandler’s 37th A...
Category : Clinical Trial Update 26 November 2025Viking Therapeutics is stepping into the spotlight this December. The metabolic-drug developer will...
Cornell Launches New Study on Once-Weekly GLP-1 Th...
Category : Clinical Trial Update 26 November 2025Feline obesity is rising fast, and veterinarians have few effective tools to manage it. Now, a Corne...
New $1.9M DoD-Funded Trial Aims to Improve Swallow...
Category : Clinical Trial Update 25 November 2025Swallowing problems, or dysphagia, affect up to 80% of people with Parkinson’s disease. These...
Novo Nordisk’s Alzheimer’s Trials Miss Primary End...
Category : Clinical Trial Update 25 November 2025Alzheimer’s drug development is shifting. For decades, the field revolved around amyloid. Toda...
Latest Newsletter Post
-
Cornell Launches New Study on Once-..
26 November 2025
-
Viking Therapeutics to Join Piper S..
26 November 2025
-
Bayer Posts Strong Phase III Result..
26 November 2025
-
GEMMABio’s Next-Gen SMA1 Gene Thera..
25 November 2025
-
Novo Nordisk’s Alzheimer’s Trials M..
25 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com